PER percheron therapeutics limited

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-198

  1. 3,543 Posts.
    lightbulb Created with Sketch. 686
    Key thing is company has no drug. The semi comfirmatory trial failed bulldozing all prior tests, results and data combined. Someone or something went wrong to the tune of what should be worth a billion dollars. I dont believe science can respond schizophrenically. Even if they come out and say - we made a mistake - which they would never do... the damage is irreversible.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 3790595 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 466666 3
View Market Depth
Last trade - 10.04am 25/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.